CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04233372
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:20.292691+00:00
Published At: 2025-09-10T00:00:00+00:00
Record Updated At: 2025-09-10
Results Posted At: 2025-09-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hiv"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-10"
protocolSection.identificationModule.nctId: "NCT04233372"
protocolSection.identificationModule.officialTitle: "Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo\u00ae) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-09-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.